Why We Can and Should Focus on Autism Prevention
In light of the recent increase in autism from 1 in 68 to 1 in 59 children in just two years, a new video by scientist Bruce Lanphear it worth watching and sharing. The video makes the case for preventing chronic diseases like autism rather than chasing down genes or finding cures. In “Cause or Cure. Is the relentless pursuit of a cure hazardous to our health?”, Dr. Lanphear says that more health and science dollars need to be directed to prevention. His approach to prevention is identifying environmental exposures that promote disease and then investing in removing these exposures.
Autism Prevalence – Examining the Myths and Truths – Video Transcript
Transcript of Video Heidi Roger: Hi. I’m Heidi Roger. I am a board of director for SafeMinds, and I am the mom of a 23-year-old man with autism. Today, we’re speaking with Dr. Walter Zahorodny, the associate professor of pediatrics at the New Jersey Medical School at Rutgers University, and director of the New Jersey […]
U.S. Autism Prevalence Rate Soars to 1 in 59 Children
National Autism Organizations Demand Emergency Meeting with Secretary of Health and Human Services and Federal Autism Coordinator to Address Crisis Related Links Letter to HHS Officials CDC Report: Prevalence of Autism Spectrum Disorder Among Children Aged 8 Years – Developmental Disabilities Monitoring Network, 11 Sites, United States, 2014 Baltimore, MD, April 26, 2018 – SafeMinds, […]
Letter to HHS Officials
The Honorable Alex Azar Secretary, U.S. Department of Health and Human Services 200 Independence Avenue, S.W. Washington, DC 20201 Dr. Ann Wagner, Ph.D. Federal Autism Coordinator Chief, Biomarker and Intervention Development for Childhood-Onset Mental Disorders Branch Division of Translational Research National Institute of Mental Health 6001 Executive Blvd., Room 7162, MSC 9617 Bethesda, MD 20892 […]
Cannabis May Have Therapeutic Benefit for Autism, Should Have Fewer Federal Restrictions
The U.S. Food and Drug Administration (FDA) and the World Heath Organization (WHO) are now reviewing whether to remove cannabis from the Schedule I Controlled Substance List. Since cannabis may have potential as a therapeutic for people with autism, SafeMinds has submitted comments to the FDA in support of reassigning cannabis to a less restricted […]
SafeMinds Comments to FDA on Cannabis & Autism
Controlled Substance Staff Center for Drug Evaluation and Research Food and Drug Administration 10903 New Hampshire Ave., Bldg. 51, Rm. 5150 Silver Spring, MD 20993-0002 RE: Docket No. FDA-2018-N-1072 for “International Drug Scheduling; Convention on Psychotropic Substances; Single Convention on Narcotic Drugs; Cannabis Plant and Resin; Extracts and Tinctures of Cannabis; Delta-9-Tetrahydrocannabinol (THC); Stereoisomers of […]
